Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. QCOM
8. IRT
9. AEO
10. MSI

Go back to Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 258.00 -2.1 (0.81%)
Previous Close $260.10    52 Week High $109.10 
Open $257.07    52 Week Low $31.38 
Day High $261.98    P/E N/A 
Day Low $253.28    EPS $-1.45 
Volume 1,426,334       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.68 -0.18 (1.21%)
Previous Close $14.86    52 Week High $5.58 
Open $14.59    52 Week Low $3.60 
Day High $14.72    P/E N/A 
Day Low $14.54    EPS $0.00 
Volume 6,007,872       

SANOFI (NASDAQ: SNY) Delayed: 42.85 -0.3 (0.7%)
Previous Close $43.15    52 Week High $44.76 
Open $43.08    52 Week Low $36.81 
Day High $43.46    P/E N/A 
Day Low $42.82    EPS $0.00 
Volume 1,946,768